1
|
Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammad S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery SL. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology 2021; 73:1074-1087. [PMID: 32464706 PMCID: PMC8557635 DOI: 10.1002/hep.31393] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Revised: 04/21/2020] [Accepted: 05/03/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND AND AIMS Disease progression in children with primary sclerosing cholangitis (PSC) is variable. Prognostic and risk-stratification tools exist for adult-onset PSC, but not for children. We aimed to create a tool that accounts for the biochemical and phenotypic features and early disease stage of pediatric PSC. APPROACH AND RESULTS We used retrospective data from the Pediatric PSC Consortium. The training cohort contained 1,012 patients from 40 centers. We generated a multivariate risk index (Sclerosing Cholangitis Outcomes in Pediatrics [SCOPE] index) that contained total bilirubin, albumin, platelet count, gamma glutamyltransferase, and cholangiography to predict a primary outcome of liver transplantation or death (TD) and a broader secondary outcome that included portal hypertensive, biliary, and cancer complications termed hepatobiliary complications (HBCs). The model stratified patients as low, medium, or high risk based on progression to TD at rates of <1%, 3%, and 9% annually and to HBCs at rates of 2%, 6%, and 13% annually, respectively (P < 0.001). C-statistics to discriminate outcomes at 1 and 5 years were 0.95 and 0.82 for TD and 0.80 and 0.76 for HBCs, respectively. Baseline hepatic fibrosis stage was worse with increasing risk score, with extensive fibrosis in 8% of the lowest versus 100% with the highest risk index (P < 0.001). The model was validated in 240 children from 11 additional centers and performed well. CONCLUSIONS The SCOPE index is a pediatric-specific prognostic tool for PSC. It uses routinely obtained, objective data to predict a complicated clinical course. It correlates strongly with biopsy-proven liver fibrosis. SCOPE can be used with families for shared decision making on clinical care based on a patient's individual risk, and to account for variable disease progression when designing future clinical trials.
Collapse
Affiliation(s)
- Mark R Deneau
- University of Utah and Intermountain Primary Children's HospitalSalt Lake CityUT
| | - Cara Mack
- University of Colorado School of MedicineAuroraCO
| | | | | | | | | | - Achiya Z Amir
- The Dana-Dwek Children's HospitalThe Tel-Aviv Medical CenterTel-Aviv UniversityTel AvivIsrael
| | | | - Marcus Auth
- Alder Hey Children's HospitalLiverpoolUnited Kingdom
| | - Annemarie Broderick
- Children's Health Ireland at Crumlin & University College DublinDublinIreland
| | | | | | | | | | | | - Katryn N Furuya
- University of Wisconsin-Madison School of Medicine and Public HealthMadisonWI
| | | | | | | | | | | | - M Kyle Jensen
- University of Utah and Intermountain Primary Children's HospitalSalt Lake CityUT
| | - Maureen M Jonas
- Boston Children's Hospital and Harvard Medical SchoolBostonMA
| | | | - Nanda Kerkar
- University of Rochester Medical CenterRochesterNY
| | | | - Kaija-Leena Kolho
- University of Helsinki Hospital and Tampere UniversityHelsinkiFinland
| | - Bart G P Koot
- Amsterdam University Medical CenterAmsterdamThe Netherlands
| | - Trevor J Laborda
- University of Utah and Intermountain Primary Children's HospitalSalt Lake CityUT
| | - Christine K Lee
- Boston Children's Hospital and Harvard Medical SchoolBostonMA
| | | | | | | | | | | | | | | | - Stacy Moroz
- University of Southern CaliforniaLos AngelesCA
| | - Nadia Ovchinsky
- Children's Hospital at MontefioreAlbert Einstein College of MedicineBronxNY
| | | | - Alexandra Papadopoulou
- First Department of PediatricsUniversity of AthensChildren's Hospital Agia SofiaAthensGreece
| | | | | | | | - Kathleen B Schwarz
- Johns Hopkins UniversityBaltimoreMD.,University of California San DiegoSan DiegoCA
| | - Uzma Shah
- Massachusetts General Hospital, Harvard Medical SchoolBostonMA
| | | | - Ruchi Singh
- Cincinnati Children's Hospital Medical CenterCincinnatiOH
| | | | | | | | - Raghu Varier
- Northwest Pediatric Gastroenterology LLCPortlandOR
| | | | | | | | - Andréanne Zizzo
- London Health Sciences CenterWestern UniversityLondonOntarioCanada
| | - Stephen L Guthery
- University of Utah and Intermountain Primary Children's HospitalSalt Lake CityUT
| |
Collapse
|
2
|
Lian T, Moroz S, Matthews J, Gosain A, Emamaullee J. Defining the “Tipping Point” to Success as a Surgeon-Scientist: An Analysis of Applicants and Awardees of the American College of Surgeons Jacobson Promising Investigator Award. J Am Coll Surg 2020. [DOI: 10.1016/j.jamcollsurg.2020.07.366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
3
|
Cleary R, Moroz S, Tippey K, Xu J, Slagle J, Weinger M, Kachnic L. Evaluating the Use of a Novel Patient-Reported Outcomes Measure in Cancer Care: A Pilot Study in Patients Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Chen S, Moroz S, Daljeet K. The Dark Triad and Breakup Distress: Indirect Effects Through Relationship Investment and Commitment. Personality and Individual Differences 2016. [DOI: 10.1016/j.paid.2016.05.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
5
|
Wlazłowski G, Holt JW, Moroz S, Bulgac A, Roche KJ. Auxiliary-field quantum Monte Carlo simulations of neutron matter in chiral effective field theory. Phys Rev Lett 2014; 113:182503. [PMID: 25396365 DOI: 10.1103/physrevlett.113.182503] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2014] [Indexed: 06/04/2023]
Abstract
We present variational Monte Carlo calculations of the neutron matter equation of state using chiral nuclear forces. The ground-state wave function of neutron matter, containing nonperturbative many-body correlations, is obtained from auxiliary-field quantum Monte Carlo simulations of up to about 340 neutrons interacting on a 10(3) discretized lattice. The evolution Hamiltonian is chosen to be attractive and spin independent in order to avoid the fermion sign problem and is constructed to best reproduce broad features of the chiral nuclear force. This is facilitated by choosing a lattice spacing of 1.5 fm, corresponding to a momentum-space cutoff of Λ=414 MeV/c, a resolution scale at which strongly repulsive features of nuclear two-body forces are suppressed. Differences between the evolution potential and the full chiral nuclear interaction (Entem and Machleidt Λ=414 MeV [L. Coraggio et al., Phys. Rev. C 87, 014322 (2013).
Collapse
Affiliation(s)
- G Wlazłowski
- Faculty of Physics, Warsaw University of Technology, Ulica Koszykowa 75, 00-662 Warsaw, Poland and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - J W Holt
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - S Moroz
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - A Bulgac
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - K J Roche
- Department of Physics, University of Washington, Seattle, Washington 98195, USA and Pacific Northwest National Laboratory, Richland, Washington 99352, USA
| |
Collapse
|
6
|
Schmidt R, Moroz S. Functional renormalization group approach to the four-body problem. EPJ Web of Conferences 2010. [DOI: 10.1051/epjconf/20100302006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
8
|
Casian D, Gutu E, Moroz S. Initial experience of subfascial endoscopic perforator vein surgery in patients with severe chronic venous insufficiency. Chirurgia (Bucur) 2007; 102:415-419. [PMID: 17966938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Subfascial Endoscopic Perforator Surgery (SEPS) is a foolproof method of treatment of perforating veins reflux without direct surgical manipulation in the area of trophic disturbances. In this paper, we present initial case series, consisted of 5 patients with severe chronic venous insufficiency (CEAP classes C4-C6), SEPS being used in complex treatment. The criteria used for selection of the patients for SEPS was presence of incompetent perforating veins in the area of trophic disturbances, confirmed by duplex scanning of the venous system. Dual-port SEPS technique with using of space-maker was performed in combination with high ligation and below-knee stripping of long saphenous vein. No early postoperative complications related to SEPS were noted. Healing of all active venous ulcers among patients in class C6 and decrease of clinical severity score in all cases were achieved during follow-up period ranged from 2 to 13 months. Results of treatment in the presented case series confirm high effectiveness of SEPS in severe chronic venous insufficiency.
Collapse
Affiliation(s)
- D Casian
- Department of General Surgery, University of Medicine and Pharmacy Nicolae Testemitanu, Chişinău, Moldova.
| | | | | |
Collapse
|
9
|
Penezina O, Komissarenko S, Tishenco L, Pavlenco A, Moroz S, Bulgakov A, Fomovskaia G. Revealing some oncofetal antigens in peripheral blood mononuclear cells of donors and patients with B-chronic lymphocytic leukemia. Leuk Res 1998; 22:1009-13. [PMID: 9783803 DOI: 10.1016/s0145-2126(98)00123-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Eidelman et al. showed that the expression of functional carcinoembryonic antigen (CEA) on the surface of cells can block terminal differentiation and maintain their proliferative capabilities. This led us to analyze the expression of CEA, trophoblast-specific beta-1-glycoprotein (TSG) and embryonic prealbumin-1 (EPA) in peripheral blood mononuclear cells (PBMs) isolated from healthy donors and patients with B-chronic lymphocytic leukemia (B-CLL). We demonstrated that the PBMs of patients with B-CLL differed from PBMs of healthy donors by having greater numbers of CEA-, EPA- and TSG-positive cells.
Collapse
Affiliation(s)
- O Penezina
- A.V. Palladin Institute of Biochemistry of the Academy of Sciences of Ukraine, Kiev
| | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
This full term male infant required a 90% enterectomy for congenital intestinal volvulus shortly after birth. The remaining small bowel consisted of 8 cm of proximal jejunum anastomosed to 5 cm of terminal ileum. The ileocecal valve was intact. Parenteral nutrition was administered for the first 21 months, including 17 months of home parenteral nutrition. The child's oral diet was mother's milk until 28 months of age when he was switched to an elemental diet. Solids were introduced at 6 months of age. Presently, at 36 months of age, the infant is off parenteral nutrition and is maintaining good nutritional status on a diet of 150 calories per kilo per day. His major problem has been an extreme allergy to cow's-milk protein. This infant is remarkable, since, despite record short bowel length, he maintained a completely normal growth and development, had remarkably few serious complications, spent relatively little time in hospital, and has documented improvement of G.I. absorption and radiographic contrast studies.
Collapse
|